Chronic chemotherapy-induced peripheral neuropathy is a substantial burden among people with cancer treated with chemotherapy, according to results of a systematic review and meta-analysis published ...

“When one hears peripheral neuropathy ... neuropathy – perhaps the most heartbreaking form is chemotherapy-induced peripheral ...

The pooled prevalence of chronic painful neuropathy is 41.22% among individuals with chemotherapy-induced peripheral neuropathy.

A systematic review of more than 700 studies explored the potential benefits of vitamin D supplementation in the oncologic setting.

University of Adelaide's Associate Professor Simran Sidhu, Leader of the Integrative Human Neurophysiology Laboratory; ...

Medically reviewed by Allison Herries, RDN Neuropathy is a debilitating type of pain caused by injury or damage to nerves.

Neuromuscular training reduces the onset of chemotherapy-induced peripheral neuropathy (CIPN), according to a study published online July 1 in JAMA Internal Medicine. Peripheral neuropathy is the ...

A team of University of Adelaide researchers is hoping to create a world-first treatment for nerve damage caused by ...

Morningstar brands and products Company Portfolio ...

Certain terpenes found in moderate to high levels in Cannabis sativa successfully relieved fibromyalgia and post-surgical pain in mouse models. | Cannabis Sciences ...

MIAMI, FL / ACCESS Newswire / March 13, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on ...

There are no effective treatments for chemotherapy-induced peripheral neuropathy, a form of chronic nerve damage caused when nerves that carry messages between the brain, the spinal chord and the ...